SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 657.80+1.6%Nov 7 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: CuttingEdge Bio2/25/2021 5:11:03 PM
   of 3557
 
REGEN-COV reduces hospitalizations and deaths in outpatients

Knowing all that was learned from this, there has to be a better system developed for future outbreaks of novel pathogens. It cannot take over 1 year to learn that what should work, works, and over a year to ramp up production. There has to be accelerated path to mass produce and use REGN- Antibody cocktail therapy next time. Capacity should be built ahead of time by govt agency.

investor.regeneron.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News